fda glp-1 compounding crackdown september 2025 Compounded GLP-1s Become Illegal, Price Cuts Roll Out FDA Warns 30 Telehealth Companies

Susceptibility to hyperosmotic stress-induced phosphatidylserine exposure increases during red blood cell storage

GLP-1 Users Want Products to Meet Their Needs About one in three current users say they have come across products marketed specifically for GLP-1 users, and more than half of current users would be more likely to purchase some products if they catered specifically to those on GLP-1 medications

Joint replacement surgeries cost $30,000 to $50,000 each

The gap between 'works in rats' and 'safe and effective in humans' has ended promising compounds before

The sustained weight loss achieved with semaglutide, as evidenced in clinical trials, suggests minimal weight regain over time when therapy is continued, highlighting its role in long-term weight management

& Xiaosheng, L